These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 459808)

  • 1. [Treatment of oncologic emergencies after cytostatic therapy].
    Möhlen KH; Beller FK
    Med Welt; 1979 Jun; 30(23):894-6. PubMed ID: 459808
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
    Bregni M; Siena S; Ravagnani F; Bonadonna G; Gianni AM
    Haematologica; 1990; 75 Suppl 1():95-8. PubMed ID: 2190885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
    Vanásek J; Filip S; Medková V; Bláha M; Maricka P; Stránský P; Vavrová J
    Neoplasma; 2001; 48(1):34-8. PubMed ID: 11327535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hyperuricemia during cytostatic therapy].
    Kolb S; Sailer D; König HJ
    Fortschr Med; 1982 Dec; 100(46):2159-61. PubMed ID: 7152443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of disseminated breast cancer with triethylen-thiophosphoramide (thio-tepa)].
    Madrigal Alonso PL; Perez Gomez FJ
    Acta Oncol (Madr); 1969; 8(2):135-42. PubMed ID: 4988905
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
    Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
    Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 8. Daunorubicin in the therapy of acute granulocytic leukemia.
    Weil M; Glidewell OJ; Jacquillat C; Levy R; Serpick AA; Wiernik PH; Cuttner J; Hoogstraten B; Wasserman L; Ellison RR; Gailani S; Brunner K; Silver RT; Rege VB; Cooper MR; Lowenstein L; Nissen NI; Haurani F; Blom J; Boiron M; Bernard J; Holland JF
    Cancer Res; 1973 May; 33(5):921-8. PubMed ID: 4512953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Emergencies in oncology].
    Nagel GA; Köberle S; Schmid I; Mayr AC; Obrecht JP
    Schweiz Med Wochenschr; 1973 Sep; 103(36):1259-62. PubMed ID: 4749052
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
    Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of VM-26 in adult malignancies.
    Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
    Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of an intermittent schedule of dibromodulcitol in breast cancer.
    Tormey DC; Falkson G; Perlin E; Bull J; Blom J; Lippman ME
    Cancer Treat Rep; 1976 Nov; 60(11):1593-6. PubMed ID: 1035505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 15. Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
    Konits PH; Van Echo DA; Aisner J; Morris D; Wiernik PH
    Am J Clin Oncol; 1982 Oct; 5(5):515-9. PubMed ID: 6758569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with ftorafur treatment in breast cancer.
    Karev NI; Blokhina NG; Vozny EK; Pershin MP
    Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
    Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
    Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
    Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences in the treatment of leukopenia due to cytostatic therapy of ovarian and breast neoplasms].
    Limburg H; Müller K; Brachetti AK
    Med Welt; 1977 Aug; 28(32-33):1304-7. PubMed ID: 562966
    [No Abstract]   [Full Text] [Related]  

  • 20. [The oncologic emergency: leukocytopenia during cytostatic therapy].
    Bruntsch U
    MMW Munch Med Wochenschr; 1979 May; 121(18):623-4. PubMed ID: 108585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.